GFM Network News


U.S. patent agency to weigh rival claims on CRISPR

Reuters — The U.S. patent agency on Tuesday will hear arguments in a heated dispute over who was first to invent a revolutionary gene-editing technology known as CRISPR. Hundreds of millions of dollars may be at stake, as the technology promises commercial applications in treating genetic diseases, engineering crops, and other areas. CRISPR works as […] Read more